To evaluate the variation of S100B levels along the AD continuum, we resorted to the AD mouse model AβPPswe/PS1A246E bearing two AD-related transgenes (APP and PSEN1) and in which Aβ deposition starts at about the age of 6 months (Oliveira et al., 2011). Here, S100B is linked to Alzheimer disease.